Filters close
Newswise: Clinical Trial Results Published in Nature Medicine Show Immunotherapy’s 
Potential in Resectable Esophageal and Gastroesophageal Junction Cancers and  the Benefits of Monitoring Circulating Tumor DNA (ctDNA) to Measure Disease Response
Released: 20-Mar-2024 7:00 AM EDT
Clinical Trial Results Published in Nature Medicine Show Immunotherapy’s Potential in Resectable Esophageal and Gastroesophageal Junction Cancers and the Benefits of Monitoring Circulating Tumor DNA (ctDNA) to Measure Disease Response
Baylor Scott and White Health

The results of a study published today in Nature Medicine show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy. The study results also show the potential for monitoring circulating tumor DNA as a predictor for future intervention.



close
3.64076